Delivery Order SPE2DR25D2104-SPE2DR26F3PBF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,700.49 to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets in quantities of 100 units. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, operates under firm fixed pricing with no set-aside designation, indicating open and competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions including malaria, lupus, and rheumatoid arthritis. The contract has a ceiling value of $14,841.40 and runs through February 22, 2023. It is a firm-fixed-price delivery order, with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Plaquenil 200 mg tablets (100-count units) with a contract value of $1,318.08. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,378.32 firm fixed-price contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $318.24 to supply 100 tablets of Plaquenil 200 mg. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 25, 2023 under the terms of the contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded a $363,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 200 tablets each of Plaquenil, an antimalarial drug. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $199.02 firm fixed price delivery order contract to supply 4561475224 PLAQUENIL 200 MG TABLET 100S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the one day period of July 12-13, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support the...
- This federal contract award, valued at $11,562.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,706.79 delivery order contract is for the supply of Plaquenil 200 mg tablets. The contract has an ultimate completion date of April 5, 2023 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PBFDelivery Order
The Defense Logistics Agency awarded a $19,604.78 delivery order to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets (100-count units) with a firm fixed price contract structure. This non-set-aside delivery order is scheduled for completion by November 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Plaquenil, an antimalarial medication commonly used in treating lupus and rheumatoid arthritis, represents one of the diverse pharmaceutical products within AmerisourceBergen's federal procurement portfolio. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies through this global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains, serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 11/14/25 |